CD274 and neoplasm: In addition, nanomaterials can also be used to co-deliver G4-targeted drugs with immunotherapeutic molecules, such as nanoencapsulated anti-PD-L1 antibodies combined with G4 modulators to enhance anti-tumor immune responses.